Physician
Crescent Medical INC.
Crescent Medical INC. was paid $879K by Medicaid between Jan 2018 and Nov 2024, across 77 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 31% of everything it billed.
33Billing provider infoCRESCENT MEDICAL INC.
MEMPHIS, TN 38116
MEMPHIS, TN 38116
33aNPI1295926590assigned 08/05/2007
33bProvider typeInternal Medicine Physician
28Total paid$879K
24GClaims109,420
24DCodes billed77
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Internal Medicine Physician providers in Tennessee
Rank by total paid#40 of 581
Median peer was paid$15K
This provider vs. median58×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,211 | $183K | |
| 2019 | 12,861 | $137K | |
| 2020 | 15,317 | $133K | |
| 2021 | 19,286 | $139K | |
| 2022 | 16,128 | $114K | |
| 2023 | 17,229 | $96K | |
| 2024incomplete | 13,388 | $77K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 31% | 9,838 | 7,530 | $276K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 7,231 | 5,437 | $114K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 8.9% | 6,515 | 4,875 | $79K |
| 99497 | 5.6% | 2,398 | 1,605 | $49K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 5.5% | 1,080 | 827 | $48K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 4.5% | 936 | 670 | $40K |
| 94375 | 4.5% | 3,479 | 2,458 | $39K | |
| 93000 | 3.8% | 3,997 | 2,857 | $33K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.0% | 7,118 | 5,119 | $26K |
| 71046 | Radiologic examination, chest; 2 views | 2.7% | 2,480 | 1,718 | $24K |
| 99401 | 2.1% | 656 | 542 | $19K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.5% | 184 | 160 | $14K |
65 more codes
| 82947 | 1.4% | 7,040 | $12K | |
| 73560 | 1.4% | 2,364 | $12K | |
| G0444 | Annual depression screening, 5 to 15 minutes | 1.0% | 1,612 | $9K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 956 | $8K |
| 82570 | <1% | 2,317 | $7K | |
| 90686 | <1% | 1,230 | $7K | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 1,727 | $7K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 92 | $6K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 1,278 | $5K |
| 81003 | <1% | 3,952 | $4K | |
| 82270 | <1% | 2,736 | $4K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 242 | $3K |
| 77080 | <1% | 326 | $3K | |
| 73521 | <1% | 418 | $2K | |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | <1% | 560 | $2K |
| 93922 | <1% | 71 | $2K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,973 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,420 | $2K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 147 | $2K |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 65 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,845 | $1K |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 65 | $1K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 585 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,196 | $1K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,316 | $1K |
| 99205 | Prolong outpt/office vis | <1% | 16 | $1K |
| 90715 | <1% | 29 | $1K | |
| 94664 | <1% | 251 | $983.27 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,867 | $824.14 |
| 82962 | <1% | 298 | $817.43 | |
| 93880 | <1% | 28 | $716.58 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 200 | $671.51 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 60 | $625.61 |
| 93925 | <1% | 46 | $592.50 | |
| G0445 | High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes | <1% | 40 | $506.59 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 50 | $484.14 |
| 99406 | <1% | 112 | $352.54 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 140 | $283.58 |
| 84156 | <1% | 1,258 | $252.30 | |
| 87210 | <1% | 51 | $185.90 | |
| 87220 | <1% | 51 | $184.29 | |
| 94760 | <1% | 56 | $124.25 | |
| 99397 | <1% | 345 | $100.92 | |
| G0008 | Administration of influenza virus vaccine | <1% | 677 | $65.73 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 51 | $28.34 |
| 99000 | <1% | 167 | $3.00 | |
| 3077F | <1% | 1,772 | $0.02 | |
| 3079F | <1% | 2,245 | $0.02 | |
| 3074F | <1% | 2,233 | $0.02 | |
| 1158F | <1% | 745 | $0.01 | |
| 3078F | <1% | 2,823 | $0.01 | |
| 1126F | <1% | 785 | $0.01 | |
| 3075F | <1% | 1,630 | $0.01 | |
| 1159F | 0% | 862 | $0.00 | |
| 1160F | 0% | 757 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 4,491 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 70 | $0.00 |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 19 | $0.00 |
| 3080F | 0% | 213 | $0.00 | |
| 1170F | 0% | 816 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 1,505 | $0.00 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 902 | $0.00 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 250 | $0.00 |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 33 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 31 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKATHAWALA, AHSAN (PRESIDENT)